NCT05580224 Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT05576909 Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation Status UNKNOWN Phase PHASE2
NCT05575622 Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase N/A
NCT05573282 Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT05564338 Efficacy and Safety of Sitravatinib Plus Tislelizumab or Placebo Plus Tislelizumab Versus Placebo as Adjuvant Treatment in Participants With Hepatocellular Carcinoma Status WITHDRAWN Phase PHASE3
NCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Status TERMINATED Phase PHASE2
NCT05557838 Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With uHCC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05550025 TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer Status UNKNOWN Phase PHASE2
NCT05546879 Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05546619 Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection Status UNKNOWN Phase NA
NCT05545124 Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence Status UNKNOWN Phase PHASE2
NCT05544253 Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC Status UNKNOWN Phase PHASE2/PHASE3
NCT05537402 LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC Status TERMINATED Phase PHASE2
NCT05536427 Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT05535998 TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT Status COMPLETED Phase N/A
NCT05534906 The Detection of Small Early Liver Cancer With Natural History Follow up Status RECRUITING Phase N/A